August 23, 2018
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- FDA approves Oxervate (cenegermin), the first drug for neurotrophic keratitis, a rare eye disease
- FDA Drug Shortages
- Etoposide Injection (Updated - Currently in Shortage)
- Methotrexate Sodium Injection (Updated - Currently in Shortage)
- Metoclopramide Injection, USP (Updated - Currently in Shortage)
- Progesterone Injection, USP (Updated - Currently in Shortage)
- Hematologic Malignancy and Oncologic Disease: Considerations for Use of Placebos and Blinding in Randomized Controlled Clinical Trials for Drug Product Development Guidance for Industry (PDF - 61KB)
- National Drug Code Directory (updated)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
.png)
No hay comentarios:
Publicar un comentario